The 3DBioPad project aims to develop a novel biocompatible and bioactive pad for the topical treatment of breastfeeding pains and post-surgical pains in breast cancer patients. By addressing two significant social challenges, such as reducing our environmental impact and improving the quality of life for women suffering from these pains, the project combines innovation in materials science, product design, 3D printing, and sustainability.

The project leverages biomass byproducts, transforming them into high-value bioactive compounds that can be integrated into a 3D-printable polymeric matrix. This approach enables the creation of a new generation of bioactive, biocompatible, and 3D-printable materials. These materials can be used to fabricate non-invasive wearable therapeutic solutions, such as lightweight, breathable pads that are personalizable and deliver localized treatment directly through the skin.

The 3DBioPad project is therefore inherently multidisciplinary because it spans from biomass waste valorization and bioactive compound extraction to material design, 3D printing, metamaterial design, and product development. It involves two research units. One coordinated by Prof. Serena Graziosi (DMEC, principal investigator) and the other led by Prof. Carmen Lammi (Department of Pharmaceutical Sciences, University of Milan). Besides, the two research units acknowledge the valuable support of the NEMOLAB research centre, particularly that of Dr. Raffaele Pugliese and his team.